Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124712794 | 12471279 | 4 | F | 201602 | 20160918 | 20160616 | 20160921 | PER | US-PFIZER INC-2016291919 | PFIZER | 73.00 | YR | F | Y | 0.00000 | 20160921 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124712794 | 12471279 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20 MG (HAD BEEN TAKING 20MG THE MAJORITY OF THE TIME) | N | 20702 | 20 | MG | FILM-COATED TABLET | |||||||
| 124712794 | 12471279 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 10 MG (SHE BEGAN WEANING OFF OF THE PRODUCT BY TAKING HALF OF HER 20MG DOSE) | N | 20702 | 10 | MG | FILM-COATED TABLET | |||||||
| 124712794 | 12471279 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20 MG | N | 20702 | 20 | MG | FILM-COATED TABLET | |||||||
| 124712794 | 12471279 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY, TABLET (ON 02JUN2016 SHE WENT BACK TO TAKING HALF OF THE TABLET, 10MG) | N | 20702 | 10 | MG | FILM-COATED TABLET | QD | |||||
| 124712794 | 12471279 | 5 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, 1X/DAY | U | 0 | 5 | MG | TABLET | QD | |||||
| 124712794 | 12471279 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | UNK, DAILY | 0 | |||||||||||
| 124712794 | 12471279 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK, DAILY | 0 | |||||||||||
| 124712794 | 12471279 | 8 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | UNK, DAILY | 0 | |||||||||||
| 124712794 | 12471279 | 9 | C | COQ10 | UBIDECARENONE | 1 | Oral | UNK UNK, DAILY | 0 | ||||||||||
| 124712794 | 12471279 | 10 | C | FISH OIL | FISH OIL | 1 | UNK, DAILY | 0 | |||||||||||
| 124712794 | 12471279 | 11 | C | CALCIUM | CALCIUM | 1 | UNK, DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124712794 | 12471279 | 1 | Blood cholesterol increased |
| 124712794 | 12471279 | 5 | Blood pressure increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124712794 | 12471279 | Drug withdrawal headache | |
| 124712794 | 12471279 | Fatigue | |
| 124712794 | 12471279 | Myalgia | |
| 124712794 | 12471279 | Pain in extremity | |
| 124712794 | 12471279 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124712794 | 12471279 | 1 | 2014 | 0 | ||
| 124712794 | 12471279 | 3 | 20160601 | 0 | ||
| 124712794 | 12471279 | 4 | 20160602 | 0 | ||
| 124712794 | 12471279 | 5 | 2015 | 0 |